SECURITIES AND EXCHANGE COMMISSION
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of August 2022
COMMISSION FILE NUMBER: 001-33373
CAPITAL PRODUCT PARTNERS L.P.
(Translation of registrants name into English)
3 Iassonos Street
Piraeus, 18537 Greece
(Address of principal executive offices)
Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
Attached to this report on Form 6-K as Exhibit I is a copy of Capital Product Partners L.P.s Board Diversity Matrix as of August 3, 2022.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|CAPITAL PRODUCT PARTNERS L.P.|
|Dated: August 3, 2022||By:||Capital GP L.L.C., its general partner|
|Name:||Gerasimos (Jerry) Kalogiratos|
|Title:||Chief Executive Officer of Capital GP L.L.C.|
BOARD DIVERSITY MATRIX (AS OF AUGUST 3, 2022)
|Country of Principal Executive Offices||Greece|
|Foreign Private Issuer||Yes|
|Disclosure Prohibited Under Home Country Law||No|
|Total Number of Directors||7|
|Part I: Gender Identity|
|Part II: Demographic Background|
|Underrepresented Individual in Home Country Jurisdiction||1|
|Did Not Disclose Demographic Background||0|